David Bouchey – Aegis Capital

Aegis Capital

An analyst at Aegis Capital with 11 tracked ratings across 9 distinct tickers has issued 7 bullish ratings, all within one source category, and has a 0% success rate on the captured sample from the other source category.

Aggregated from multiple market-data sources

Total ratings

Tickers covered

Sources

Aggregated

Latest rating

8 months ago

2025-10-08 00:00:00+00

Track record

Aggregated

50% success rate

Bullish: 3
Hold: 0
Bearish: 1

Aggregated

Not available

Bullish: 8
Hold: 0
Bearish: 0

Recent ratings

Ticker	Date	Rating	Price target	Source
AEON	2025-10-08	buy	$7.20	Aggregated
SBFM	2025-10-08	sell	$7.00	Aggregated
SBFMSUNSHINE BIOPHARMA INC	2025-10-08	unknown	$7.00	Aggregated
SBFM	2024-12-05	buy	$15.00	Aggregated
SBFM	2023-08-07	buy	$2.60	Aggregated
STSS	2023-05-09	buy	$16.00	Aggregated
STSSSHARPS TECHNOLOGY INC	2023-05-09	unknown	$16.00	Aggregated
ATXI	2023-04-03	buy	$32.00	Aggregated
ATXIAVENUE THERAPEUTICS INC	2023-04-03	unknown	$32.00	Aggregated
IINN	2023-01-25	buy	$13.00	Aggregated
IINNINSPIRA TECHNOLOGIES OXY B.H.N. LTD	2023-01-25	unknown	$13.00	Aggregated
QTEX	2023-01-25	buy	$13.00	Aggregated

Tickers covered(10)

Ticker	Ratings	Last rating	Sources
AEON	1	2025-10-08	Aggregated
SBFM	5	2025-10-08	Aggregated
SBFMSUNSHINE BIOPHARMA INC	1	2025-10-08	Aggregated
STSS	3	2023-05-09	Aggregated
STSSSHARPS TECHNOLOGY INC	1	2023-05-09	Aggregated
ATXI	3	2023-04-03	Aggregated
ATXIAVENUE THERAPEUTICS INC	1	2023-04-03	Aggregated
IINN	3	2023-01-25	Aggregated
IINNINSPIRA TECHNOLOGIES OXY B.H.N. LTD	1	2023-01-25	Aggregated
QTEX	1	2023-01-25	Aggregated

Methodology differs by source. Track records are aggregated from multiple sources; scoring methodology and scales differ by source and values are not directly comparable. Coverage is sourced from publicly-aggregated analyst activity. Past performance does not guarantee future results. Not investment advice.